相关实验视频
Updated: Jul 23, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
15.9K
SPARC:功能纳米材料和药物的潜在目标
Shan Jiang1,2, Hui-Feng Sun1, Shuang Li2,3
1School of Pharmacy, Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
Frontiers in molecular biosciences
|August 14, 2023
概括
分泌的蛋白酸性和丰富的氨酸 (SPARC) 在癌症和炎症等疾病中起着关键作用. 用功能性纳米材料准SPARC为诸如风湿性关节炎和瘤等疾病提供了新的治疗策略.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 纳米医学是一种纳米医学.
背景情况:
- 分泌蛋白酸性和富含氨酸 (SPARC) 是一种调节细胞-细胞外基质相互作用的母细胞蛋白.
- SPARC影响细胞粘附,增殖和生长因子活动.
- 在各种病理条件中观察到SPARC的过度表达,包括炎症,肥胖和癌症.
研究的目的:
- 总结SPARC在炎症和瘤中的过度表达机制.
- 审查功能纳米材料的进展,以SPARC为疾病治疗的目标.
- 提供有关SPARC针对炎症性疾病和癌症的向治疗的见解.
主要方法:
- 关于SPARC功能和过度表达的综合文献综述.
- 对用于SPARC向治疗的功能纳米材料研究的分析.
- 在类风湿性关节炎和瘤中的治疗应用信息的综合.
主要成果:
- 详细介绍了SPARC在调节细胞过程中的作用及其在疾病状态中的过度表达.
- 功能性纳米材料在操纵SPARC治疗干预方面表现有前途.
- 目前正在探索针对类风湿关节炎和各种癌症的SPARC向策略.
结论:
- 在炎症性疾病和癌症中,SPARC是治疗策略的重要目标.
- 功能性纳米材料为SPARC向性疾病治疗提供了一种新的方法.
- 对SPARC向治疗的进一步研究有可能改善疾病管理.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

